ClinicalTrials.Veeva

Menu

Observational Study With Investigation of Two Second Generation Laryngeal Masks (OSSGA)

J

Johannes Gutenberg University (JGU)

Status

Completed

Conditions

Airway Remodeling

Treatments

Device: Success

Study type

Observational

Funder types

Other

Identifiers

NCT02566291
SGA 2014

Details and patient eligibility

About

In a observational study the second-generation laryngeal masks LMA Supreme and Ambu AuraGain are investigated.

Full description

After approval from the local ethics committee, data were collected in a prospective, non- randomised study over a three-month period. When contra-indications for laryngeal mask use were absent anaesthesiologists used either Supreme (Teleflex Medical GmbH, Germany) or Gain (Ambu GmbH, Germany). Endpoints were the success rate and time to insertion.

Enrollment

364 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥ 18 Years
  • No concurrent participation in another study
  • capacity to consent
  • Present written informed consent of the research participant
  • Elective surgery under general anesthesia

Exclusion criteria

  • Age <18 years
  • Existing pregnancy
  • Lack of consent
  • inability to consent
  • emergency patients
  • Emergency situations in the context of a Difficult Airway Management
  • ASA classification> 3
  • situations where the possibility of accumulated gastric contents
  • Participation in another study

Trial design

364 participants in 2 patient groups

Supreme Group
Description:
Measuring Success rate and Insertion Time
Treatment:
Device: Success
Gain Group
Description:
Measuring Success rate and Insertion Time
Treatment:
Device: Success

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems